Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2026-03-29 @ 7:03 AM
Study NCT ID:
NCT04573556
Status:
COMPLETED
Last Update Posted:
2022-04-05
First Post:
2020-09-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Safety of DAYVIGO (Lemborexant) Tablets in Participants With Insomnia.
Sponsor:
Eisai Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-17
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-17
Completion Date Type:
ACTUAL
First Submit Date:
2020-09-29
First Submit QC Date:
None
Study First Post Date:
2020-10-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-04
Last Update Post Date:
2022-04-05
Last Update Post Date Type:
ACTUAL